The Neuroendocrine Tumor Research Foundation (NETRF) is pleased to collaborate with the International Neuroendocrine Cancer Alliance (INCA) to share the results from the Survey of
Update February 2024: Click here to read a recently published commentary in the journal Cancer about NET-PRO study The Patient-Centered Outcomes Research Institute (PCORI) recently
NETRF Announces Leadership Changes to the Board of Scientific Advisors It is with gratitude and profound respect that The Neuroendocrine Tumor Research Foundation (NETRF) announces
Building A Friendship and a Foundation to Fight NETs Anne Doyle received news that no daughter wants to hear in 1993. Her father Hugh had
The Neuroendocrine Tumor Research Foundation (NETRF) continues to build a global community of researchers as scientists from around the world recognize they are eligible to
The Mueller and Sells family have faced many obstacles since Katherine Mueller was diagnosed with neuroendocrine cancer. They have pushed forward to help fund research,
The Neuroendocrine Tumor Research Foundation (NETRF) has awarded $2.62 million in grants to advance research aimed at finding new and innovative treatments for neuroendocrine tumors
Thank you for supporting NET research in 2020 Together we can fund research needed to find a cure for neuroendocrine cancer The 2020 results are
Honoring Jan’s legacy Ed Peine remembers the first time that he and his wife Jan met Nancy Lindholm, the founder of Caring for Carcinoid, at
By Josh Mailman Being a NET patient usually means some amount of travel for our care. While the pandemic has negatively impacted almost every aspect
